Direct federal R&D spending in the Czech Republic reached CZK 30.7 billion ($1.3 billion) in 2017, a 9.6% jump. Private business R&D received CZK 3 billion ($131.7 million) from the government, rising 15.4%. To calculate public funding of R&D, the Government Budget Appropriations on R&D (GBARD) is examined for direct funding, and statistics of Government Tax Incentives for R&D expenditures (GTARD) are measured to calculate indirect public support for R&D. In 2016, indirect support for R&D through GTARD reached CZK 2.4 billion ($105.3 million). 2017 figures are not yet available.

The Czech government provides budget allocations for R&D based on 13 specific socioeconomic objectives, which include: protection and improvement of human health; production, distribution and rational utilization of energy; agricultural production and technology; and research financed from General University Funds (GUF).

In the health category, CZK 2.4 billion ($105.3 million) was allocated by the government to R&D, which represented 8% of total GBARD. The vast majority of this funding, or 89%, was for medical research, hospital treatment and surgery, totaling CZK 2.1 billion ($93.2 million). Biomedical engineering and medicines GBARD was CZK 154.1 million ($6.8 million), while nutrition and food hygiene GBARD reached CZK 41.1 million ($1.8 billion). Other medical research GBARD was CZK 20.6 million ($904.1 thousand).

Approximately 61% of energy GBARD was for nuclear fission, which received CZK 635.1 million ($27.9 million) in funding. Renewable energy soures received CZK 57.1 million ($2.5 million), and general research received CZK 5.4 million ($237.0 thousand). Agricultural technology GBARD was allocated CZK 529.4 million ($23.2 million), which represented 44% of total agricultural GBARD. This was followed by veterinary medicine and animal products, which received CZK 203.6 million ($8.9 million) and CZK 162.9 million ($7.1 million), respectively.

Within research financed from general university funds, engineering sciences received the greatest GBARD allocation at 20%, at CZK 1.4 billion ($60.5 million). Medical sciences and biological sciences received CZK 701.3 million ($30.8 million) and CZK 695.4 million ($30.5 million), respectively, while chemical and physical sciences received CZK 776.4 million ($34.1 million) and CZK 671.9 million ($29.5 million), respectively.

Source: Czech Statistical Office